Adenosine A2B Receptor: A Pathogenic Factor and a Therapeutic Target for Sensorineural Hearing Loss

    December 2020 in “ The FASEB Journal
    Jeanne M. Manalo, Hong Liu, Dalian Ding, John Hicks, Hong Sun, Richard Salvi, Rodney E. Kellems, Fred A. Pereira, Yang Xia
    New to Adenosine? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary Blocking adenosine A2B receptor may prevent or treat hearing loss.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The adenosine A2B receptor is a potential therapeutic target for sensorineural hearing loss, as blocking it may prevent or treat hearing loss. Studies on mice suggest that elevated adenosine levels can cause nerve fiber demyel
    Discuss this study in the Community →